This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Fmc Corporation, Theravance Biopharma R&d IP, LLC, E.i. Dupont De Nemours and Company. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Madera, CA (US) (2017 - 2023)
- San Francisco, CA (US) (2023)
Company Filing History:
3 out of 2,517 
2 out of 262 
1 out of 16,339 
Years Active: 2017-2023
Title: Breena Gloriana Fraga: Innovative Inventor in Pharmaceutical Chemistry
Introduction
Breena Gloriana Fraga is a distinguished inventor based in Madera, California, recognized for her contributions to pharmaceutical chemistry. With a remarkable portfolio of six patents, she has developed innovative compounds aimed at addressing significant health challenges.
Latest Patents
Fraga's latest patents include the development of "Fused pyrimidine pyridinone compounds as JAK inhibitors." This patent discloses compounds that serve as inhibitors of JAK kinases, specifically JAK3, and offers pharmaceutical compositions that utilize these compounds for treating gastrointestinal inflammatory diseases. Another significant patent involves "Heterocycle-substituted bicyclic azole pesticides," which presents compounds that effectively control invertebrate pests. The disclosure outlines methods for utilizing these compounds in pest management by administering them to affected environments.
Career Highlights
Throughout her career, Fraga has made impactful strides in research and development, particularly in the pharmaceutical industry. She has worked with notable companies, including FMC Corporation and Theravance Biopharma R&D IP, LLC. Her work has been pivotal in advancing therapeutic solutions through innovative compound development.
Collaborations
Fraga’s collaborations with prominent professionals, such as David Alan Clark and Wenming Zhang, reflect her ability to work within interdisciplinary teams to enhance research outcomes. These partnerships have contributed significantly to her innovative projects and the success of her patent applications.
Conclusion
Breena Gloriana Fraga exemplifies the spirit of innovation through her extensive contributions to the field of pharmaceutical chemistry. Her patents not only address critical medical issues but also showcase her dedication to advancing science. As she continues to pave the way for new discoveries, her work stands as a testament to the impact of inventive minds in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile